Non-steroidal anti-inflammatory drugs in pregnancy

Czech version

Authors: P. Valha ¹; J. Zmrhal ²; J. Feyereisl ¹
Authors‘ workplace: Ústav pro péči o matku a dítě, Praha ¹; Nemocnice s poliklinikou, Mělník ²
Published in: Ceska Gynekol 2010; 75(1): 69-72

Overview

Non-steroidal anti-inflammatory drugs, usually abbreviated to NSAIDs, are drugs with analgesic, antipyretic (lowering an elevated body temperature and relieving pain without impairing consciousness) and, in higher doses, with anti-inflammatory effects (reducing inflammation). As inhibitors of cyclooxygenase NSAIDs given during pregnancy have the potential to cause adverse maternal and fetal effects. Maternal effects include prolongation of pregnancy and labour, whereas constriction of the ductus arteriosus, renal dysfunction and haemostatic abnormalities can occur in the fetus and neonate. As weak acids, NSAIDs are excreted in small amounts into human breast milk with little risk for adverse effects in the suckling infant.

Key words:
cyclooxygenase inhibitors, ductus arteriosus, lactation, pregnancy/labour.

Sources

1. Hynie, S. Speciální farmakologie. Praha: Karolinum, 1998.

2. Hájek, Z., a kol. Rizikové a patologické těhotenství. Praha: Galén, 2004.

3. Zwinger, A., et.al. Porodnictví. Praha: Galén, 2004.

4. Lippincott Pharmacology 2^nd ed. New York: Lippincott comp. 1997.

5. National Poisons Informatory Service, United Kingdom – Aspirin and non-steroidal anti-inflamatory agents.

6. Nielsen, S, Larsen, P. Risk of adverse birth outcome and miscarriage in pregnant users of non- steroidal anti-inflamatory drugs. Brit Med J, 2001.

7. Alano, MA., Ngougmna, EM., Ostrea, Jr. Analysis of NSAId in meconium and its relation to persistent pulmonary hypertension of the newborn. Pediatrics, 2004, 107, 3.

8. Markis, A., Thornton, C. Hennesy, A. Postpartum hypertension and nonsteroidal analgesia. Am J Obstet Gynecol, 2003, 5.

9. Aranow, C. Non-steroidal anti-inflamatory drugs. Lupus Foundation of America 2005.

10. De-Kun Li, Liyan Liu, Odouli, R. Exposure to non-steroidal anti-inflamatory drugs during pregnancy and risk of miscarriage – population based cohort study. Brit Med J, 2003, 16.

11. Hussain, SM., Parke, AL. The use of antirheumaic disease drugs durin pregnancy. Future Med, 2006, 2.

12. Ericson, A., Bengt, A., Kallen, J. Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol, 2001, 15, p. 371-375.

13. Chambers, CD., Tutunca, ZN., Johnson, D., Jones, KL. Human pregnant safety for agents used to treat rheumatoid arthritis, adequacy of available information and strategies for developing post-marketing data. Arthritis Res Ther, 2006, 14, 6.

14. Alex, O. NSAID used in pregnancy linked to pulmonary hypertension in newborn. MedScape Today 1997.

15. Merck Manual 2004. Persistent Pulmonary Hypertension.